Written Question·Department of Health and Social Care·UIN 50771

Hormone Replacement Therapy

Tabled: 7 May 2025

Answered: 12 May 2025

Named Day

Question

Freddie van Mierlo

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2025 to Question 35541 on Hormone Replacement Therapy, what discussions he has had with the Medicines and Healthcare products Regulatory Agency on the adequacy of

Answer

Karin Smyth

The processes of the Medicines and Healthcare products Regulatory Agency (MHRA) are now performing within the expected timelines, and are meeting company commitments. Guidance has been updated on 3 April 2024 to aid the rapid approval of medicines, ensuri...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 50771) →